Maari, Catherine
Innovaderm (Canada) · Université de Montréal
2 papers on CoChatORCID 0000-0002-9719-0810
Most cited papers
- Verified
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 522
- Verified
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 220
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free